Shahlaei et al., 2011 - Google Patents
Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulationShahlaei et al., 2011
View HTML- Document ID
- 7799899139399164542
- Author
- Shahlaei M
- Madadkar-Sobhani A
- Mahnam K
- Fassihi A
- Saghaie L
- Mansourian M
- Publication year
- Publication venue
- Biochimica et Biophysica Acta (BBA)-Biomembranes
External Links
Snippet
In this study, homology modeling, molecular docking and molecular dynamics simulation were performed to explore structural features and binding mechanism of some inhibitors of chemokine receptor type 5 (CCR5), and to construct a model for designing new CCR5 …
- 230000027455 binding 0 title abstract description 135
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
- G06F19/706—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
- G06F17/30861—Retrieval from the Internet, e.g. browsers
- G06F17/30864—Retrieval from the Internet, e.g. browsers by querying, e.g. search engines or meta-search engines, crawling techniques, push systems
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
- G06F19/701—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for molecular modelling, e.g. calculation and theoretical details of quantum mechanics, molecular mechanics, molecular dynamics, Monte Carlo methods, conformational analysis or the like
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/22—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for sequence comparison involving nucleotides or amino acids, e.g. homology search, motif or SNP [Single-Nucleotide Polymorphism] discovery or sequence alignment
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shahlaei et al. | Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation | |
| Cavasotto et al. | Computational chemistry in drug lead discovery and design | |
| Venkatakrishnan et al. | Uncovering patterns of atomic interactions in static and dynamic structures of proteins | |
| Jogini et al. | Dynamics of the Kv1. 2 voltage-gated K+ channel in a membrane environment | |
| Yin et al. | Crystal structure of the human NK1 tachykinin receptor | |
| Abaffy et al. | The molecular basis for ligand specificity in a mouse olfactory receptor: a network of functionally important residues | |
| Suhre et al. | Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2 | |
| Salmas et al. | Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions | |
| Almerico et al. | A3 adenosine receptor: Homology modeling and 3D-QSAR studies | |
| Floris et al. | Adenosiland: walking through adenosine receptors landscape | |
| Liu et al. | A structure-based approach to understanding somatostatin receptor-4 agonism (sst4) | |
| Méndez-Luna et al. | Understanding the molecular basis of agonist/antagonist mechanism of GPER1/GPR30 through structural and energetic analyses | |
| Mansourian et al. | Insights into the human A1 adenosine receptor from molecular dynamics simulation: structural study in the presence of lipid membrane | |
| Sokkar et al. | Multiple templates-based homology modeling enhances structure quality of AT1 receptor: validation by molecular dynamics and antagonist docking | |
| Pal et al. | Structure based prediction of a novel GPR120 antagonist based on pharmacophore screening and molecular dynamics simulations | |
| Ekhteiari Salmas et al. | Biological insights of the dopaminergic stabilizer ACR16 at the binding pocket of dopamine D2 receptor | |
| Ekhteiari Salmas et al. | A QM protein–ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R) | |
| Li et al. | Molecular insights into the D1R agonist and D2R/D3R antagonist effects of the natural product (−)-stepholidine: molecular modeling and dynamics simulations | |
| Gadhe et al. | Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach | |
| Shahlaei et al. | Molecular dynamics simulation of chemokine receptors in lipid bilayer: a case study on C–C chemokine receptor type 2 | |
| Jatana et al. | Structure and dynamics of DRD 4 bound to an agonist and an antagonist using in silico approaches | |
| Naresh et al. | Enhanced metastable state models of TAM kinase binding to cabozantinib explains the dynamic nature of receptor tyrosine kinases | |
| Seshan et al. | Insights of structure-based pharmacophore studies and inhibitor design against Gal3 receptor through molecular dynamics simulations | |
| Wang et al. | Understanding the molecular mechanism of endothelin ETA receptor selecting isopeptides endothelin-1 and-3 | |
| Sheftel et al. | Graph analysis of β2 adrenergic receptor structures: a “social network” of GPCR residues |